Facebook and Instagram have announced that they will remove posts promoting ‘miracle’ cures and get-slim-quick products.
News
IAOCR launches patient safety campaign
‘Don’t Risk Your Research’ aims to raise awareness of the risks incompetence poses to patients, clinical research and organisations.
FDA Breakthrough granted for Roche’s Gazyva
The designation was based on the Phase II NOBILITY study.
Oral semaglutide trumps Jardiance, Januvia, Victoza in type II diabetes
Type II diabetes costs the NHS £8.8 billion a year.
Cosentyx bags positive results in potential new indication
Novartis has also submitted to the EMA for approval in the disease, non-radiographic axial spondyloarthritis.
NICE recommends Takhzyro
The recommendation was made based partly on data from the HELP-03 Study, in which Takhzyro reduced the mean number of monthly HAE attacks by 87%.
MHRA, Bill & Melinda Gates foundation team up for medicine safety whilst pregnant
Research on the topic is vital yet sparse, as data in this area remain limited.
Happify, Sanofi to advance digital therapeutics for MS
The therapeutics will address key co-morbidities for individuals living with the disease.
Acceleron abandons muscular dystrophy drug
The company will not conduct any further trials.
PharmaTimes are excited to announce the launch of the 2020 International Clinical Researcher of the Year competition!
The prestigious and long standing International Clinical Researcher of the Year competition has launched for the 21st year – flying the flag for excellence in global clinical research.
MyMeds&Me launch mobile drug safety site
The platform is optimised to work on any device, across multiple regions and languages.
ABPI, Birmingham Health Partners team up for health challenges
The collaboration will play to Birmingham’s strengths in healthcare data and digitalisation of health care services.
Boehringer to launch first reusable soft mist inhaler
Pharmacists are likely to see people with COPD and asthma more regularly than a GP or nurse, so they play a pivotal role in educating patients on their medicines and inhaler technique.
Santen’s Ikervis effective for dry eye
The treatment proved effectiveness, tolerability and safety in the PERSPECTIVE trial.
Age ‘shouldn’t be a barrier’ in adopting tech in NHS
In 2019, 91% of adults in the UK are recent internet users, but just 47% of adults aged 75 years and over are.
